Publications

Detailed Information

New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes

DC Field Value Language
dc.contributor.authorKwak, Nakwon-
dc.contributor.authorLee, Jong Hyuk-
dc.contributor.authorKim, Hyung-Jun-
dc.contributor.authorKim, Sung A-
dc.contributor.authorYim, Jae-Joon-
dc.date.accessioned2021-01-18T05:04:37Z-
dc.date.available2021-01-18T14:06:10Z-
dc.date.issued2020-11-10-
dc.identifier.citationBMC Pulmonary Medicine. 2020 Nov 10;20(1):293ko_KR
dc.identifier.issn1471-2466-
dc.identifier.urihttps://hdl.handle.net/10371/171653-
dc.description.abstractBackground
The close association between bronchiectasis and nontuberculous mycobacterial pulmonary disease (NTM-PD) is well-known. However, the clinical impact of subsequent new-onset NTM-PD in bronchiectasis patients has not been elucidated. The aim of this study is to investigate the clinical courses and radiographic changes of patients with bronchiectasis in whom NTM-PD subsequently developed.

Methods
A total of 221 patients with bronchiectasis who had participated in a non-NTM bronchiectasis cohort between July 1st 2011 and August 31st 2019 at Seoul National University Hospital were included in this study. The data of patients in whom NTM-PD developed during this observation period were analyzed; specifically, changes in the Bronchiectasis Severity Index (BSI) and lesions on computerized tomography (CT) scan of the chest arising during the observation period.

Results
During the observation period, NTM was isolated from 35 patients. A total of 31 patients (14.0%) satisfied the diagnostic criteria of NTM-PD. The median time from enrollment in the cohort to the development of subsequent NTM-PD was 37 months (Interquartile range [IQR], 18–78 months). Mycobacterium avium complex was the most common pathogen (80.6%). Twelve patients underwent antibiotic treatment for NTM-PD with a median interval of 20 months (IQR, 13–30) from the time of NTM-PD diagnosis. When NTM-PD developed, the severity and extent of bronchiectasis, cellular bronchiolitis, and the extent of nodules worsened on CT scans, while BSI did not change.

Conclusions
NTM-PD can develop in previously negative bronchiectasis patients. It is associated with worsening radiographic lesions. Active screening of non-NTM bronchiectasis patients for new-onset NTM infection should be considered, especially if radiographic findings worsen. The BSI is not a reliable predictor of new-onset NTM-PD.


Trial registration
This study was performed at Seoul National University Hospital (
NCT01616745

).
ko_KR
dc.language.isoenko_KR
dc.publisherBMCko_KR
dc.subjectMycobacterium-
dc.subjectIncidence-
dc.subjectInfection-
dc.titleNew-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changesko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1186/s12890-020-01331-3-
dc.citation.journaltitleBMC Pulmonary Medicineko_KR
dc.language.rfc3066en-
dc.rights.holderThe Author(s)-
dc.date.updated2020-11-15T04:06:54Z-
dc.citation.number1ko_KR
dc.citation.startpage293ko_KR
dc.citation.volume20ko_KR
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share